Murine pulmonary responses after sub-chronic exposure to aluminum oxide-based nanowhiskers

Particle and Fibre Toxicology

Volumn 9, Issue , 2012, Pages

  Adamcakova Dodd, Andrea ^a   Stebounova, Larissa V ^b   O'Shaughnessy, Patrick T ^a   Kim, Jong S ^a   Grassian, Vicki H ^a,b   Thorne, Peter S ^a  

^a UNIVERSITY OF IOWA   (United States)

^b University of Iowa   (United States)

Author keywords

Aluminum; High aspect ratio nanomaterial; Inhalation; Murine model; Nanowhiskers; Pulmonary response; Toxicity

Indexed keywords

ALUMINUM OXIDE; ALUMINUM OXIDE NANOWHISKER; GAMMA INTERFERON; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 2; NANOMATERIAL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AEROSOL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOLUTION; DOSIMETRY; DRY WEIGHT; ENZYME ACTIVITY; HEART; HEMATOLOGY; HISTOPATHOLOGY; IN VIVO STUDY; LIVER; LONG TERM EXPOSURE; LUNG; LUNG FUNCTION; LUNG LAVAGE; LUNG MECHANICS; LUNG TOXICITY; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SHAM PROCEDURE; SPLEEN; TOXICITY TESTING;

ADMINISTRATION, INHALATION; AEROSOLS; ALUMINUM OXIDE; ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CYTOKINES; INHALATION EXPOSURE; L-LACTATE DEHYDROGENASE; LUNG; MACROPHAGES; MALE; METAL NANOPARTICLES; MICE; MICE, INBRED C57BL; PARTICLE SIZE; TISSUE DISTRIBUTION; TOXICITY TESTS;

ANIMALIA; MURINAE; MUS;

EID: 84862288104     PISSN: None     EISSN: 17438977     Source Type: Journal    
DOI: 10.1186/1743-8977-9-22     Document Type: Article

References (49)

1. Xia Y, Yang P, Sun Y, Wu Y, Mayers B, Gates B, Yin Y, Kim F, Yan H. One-Dimensional Nanostructures: Synthesis, characterization, and applications. Adv Mater 2003, 15(5):353-389.
2. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB. Safe handling of nanotechnology. Nature 2006, 444(7117):267-269. 10.1038/444267a, 17108940.
3. Elder A, Yang H, Gwiazda R, Teng X, Thurston S, He H, Oberdörster G. Testing nanomaterials of unknown toxicity: an example based on platinum nanoparticles of different shapes. Adv Mater 2007, 19(20):3124-3129.
4. Tomatis M, Turci F, Ceschino R, Riganti C, Gazzano E, Martra G, Ghigo D, Fubini B. High aspect ratio materials: role of surface chemistry vs. length in the historical "long and short amosite asbestos fibers". Inhal Toxicol 2010, 22(12):984-998. 10.3109/08958378.2010.504243, 20718637.
5. Donaldson K, Murphy FA, Duffin R, Poland CA. Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Particle and fibre toxicology 2010, 7:5. 10.1186/1743-8977-7-5, 2857820, 20307263.
6. Turci F, Tomatis M, Lesci IG, Roveri N, Fubini B. The iron-related molecular toxicity mechanism of synthetic asbestos nanofibres: A model study for high-aspect-ratio nanoparticles. Chemistry (Weinheim an der Bergstrasse, Germany)
7. Tran CL, Hankin SM, Ross B, Aitken RJ, Jones AD, Donaldson K, Stone V, Tantra R. An outline scoping study to detrmine whether or not high-aspect-ration nanoparticles (HARN) should raise the same concerns as do asbesots fibers 2008, Institute of Occupational Medicine, Edinburgh.
8. Poland CA, Duffin R, Kinloch I, Maynard A, Wallace WA, Seaton A, Stone V, Brown S, Macnee W, Donaldson K. Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. Nat Nanotechnol 2008, 3(7):423-428. 10.1038/nnano.2008.111, 18654567.
9. Donaldson K, Murphy F, Schinwald A, Duffin R, Poland CA. Identifying the pulmonary hazard of high aspect ratio nanoparticles to enable their safety-by-design. Nanomedicine (London, England) 2011, 6(1):143-156.
10. Murphy F A, Polland CA, Duffin R, Al-Jamal K T, Ali-Boucetta H, Nunes A, Byrne F, Prina-Mello A, Volkov Y, Li S, Mather SJ, Bianco A, Prato M, Macnee W, Wallace WA, Kostarelos K, Donaldson K. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am J Pathol 2011, 178(6):2587-2600. 10.1016/j.ajpath.2011.02.040, 3124020, 21641383.
11. Kane AB, Hurt RH. Nanotoxicology: the asbestos analogy revisited. Nat Nanotechnol 2008, 3(7):378-379. 10.1038/nnano.2008.182, 18654556.
12. Hamilton RF, Wu N, Porter D, Buford M, Wolfarth M, Holian A. Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Particle and fibre toxicology 2009, 6:35. 10.1186/1743-8977-6-35, 2806338, 20043844.
13. Liu X, Guo L, Morris D, Kane AB, Hurt RH. TTargeted removal of bioavailable metal as a detoxification strategy for carbon nanotubes. Carbon N Y 2008, 46(3):489-500. 2614279, 19255622.
14. Miller J, Cho KJ, McGehee M. A realistic assessment of the commercialization of nanotechnology: A primer for lawyers and investors. Nanotechnology Law & Business 2004, 1(1):1-13.
15. Meliorum Technologies I List of Applications. Aluminum Oxide Nanomaterials 2008, , , [cited 2011 10/27/2011]; Available from: http://www.meliorum.com/fullapplicationslist.htm, Meliorum Technologies I.
16. Thorne PS. Experimental grain dust atmospheres generated by wet and dry aerosolization techniques. American journal of industrial medicine 1994, 25(1):109-112. 10.1002/ajim.4700250129, 8116632.
17. Weyel DA, Ellakkani M, Alarie Y, Karol M. An aerosol generator for the resuspension of cotton dust. Toxicol Appl Pharmacol 1984, 76(3):544-547. 10.1016/0041-008X(84)90359-4, 6506079.
18. Pettibone JM, Adamcakova-Dodd A, Thorne PS, O'Shaughnessy PT, Weydert JA, Grassian VH. Inflammatory response of mice following inhalation exposure to iron and copper nanoparticles. Nanotoxicology 2008, 1:1-16.
19. Stopford W, Turner J, Cappellini D, Brock T. Bioaccessibility testing of cobalt compounds. J Environ Monit 2003, 5(4):675-680. 10.1039/b302257a, 12948248.
20. Cheng YS, Barr EB, Yeh HC. A venturi disperser as a dry powder generator for inhalation studies. Inhal Toxicol 1989, 1(4):365-371.
21. O'Shaughnessy PT, Achutan C, O'Neill ME, Thorne PS. A small whole-body exposure chamber for laboratory use. Inhal Toxicol 2003, 15(3):251-263. 10.1080/08958370304504, 12579456.
22. Murthy S, Adamcakova-Dodd A, Perry SS, Tephly LA, Keller RM, Metwali N, Meyerholz DK, Wang Y, Glogauer M, Thorne PS, Carter AB. Modulation of reactive oxygen species by Rac1 or catalase prevents asbestos-induced pulmonary fibrosis. Am J Physiol 2009, 297(5):L846-55.
23. Park H, Grassian VH. Commercially manufactured engineered nanomaterials for environmental and health studies: important insights provided by independent characterization. Environmental toxicology and chemistry / SETAC 2010, 29(3):715-721. 10.1002/etc.72, 20821499.
24. Navarro E, Piccapietra F, Wagner B, Marconi F, Kaegi R, Odzak N, Sigg L, Behra R. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ Sci Technol 2008, 42(23):8959-8964. 10.1021/es801785m, 19192825.
25. Kloprogge JT, Duong LV, Wood BJ, Frost RL. XPS study of the major minerals in bauxite: gibbsite, bayerite and (pseudo-)boehmite. J Colloid Interface Sci 2006, 296(2):572-576. 10.1016/j.jcis.2005.09.054, 16236302.
26. Asgharian B, Price OT. Airflow distribution in the human lung and its influence on particle deposition. Inhal Toxicol 2006, 18(10):795-801. 10.1080/08958370600748687, 16774869.
27. Cassee FR, Freijer JI, Subramaniam R, Asgharian B, Miller FJ, van Bree L, Rombout PJA. Development of a model for human and rat airway particle deposition: implications for risk assessment 1999 1999, Dutch National Institute of Public Health and Environment (RIVM), Bilthoven, the Netherlands.
28. Stone KC, Mercer RR, Gehr P, Stockstill B, Crapo JD. Allometric relationships of cell numbers and size in the mammalian lung. American journal of respiratory cell and molecular biology 1992, 6(2):235-243.
29. Grassian VH, O'Shaughnessy PT, Adamcakova-Dodd A, Pettibone JM, Thorne PS. Inhalation exposure study of titanium dioxide nanoparticles with a primary particle size of 2 to 5 nm. Environ Heal Perspect 2007, 115(3):397-402.
30. Grassian VH, Adamcakova-Dodd A, Pettibone JM, O'Shaughnessy PT, Thorne PS. Inflammatory response of mice to manufactured titanium dioxide nanoparticles: Comparison of size effects through different exposure routes. Nanotoxicology 2007, 1(3):211-226.
31. Stebounova LV, Adamcakova-Dodd A, Kim JS, Park H, O'Shaughnessy PT, Grassian VH, Thorne PS. Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation model. Particle and fibre toxicology 2011, 8(1):5. 10.1186/1743-8977-8-5, 3040688, 21266073.
32. Kim JS, Adamcakova-Dodd A, O'Shaughnessy PT, Grassian VH, Thorne PS. Effects of copper nanoparticle exposure on host defense in a murine pulmonary infection model. Particle and fibre toxicology 2011, 8:29. 10.1186/1743-8977-8-29, 3193802, 21943386.
33. Schmoll LH, Elzey S, Grassian VH, O'Shaughnessy PT. Nanoparticle aerosol generation methods from bulk powders for inhalation exposure studies. Nanotoxicology 2009, 3(4):265-275.
34. Kaegi R, Ulrich A, Sinnet B, Vonbank R, Wichser A, Zuleeg S, Simmler H, Brunner S, Vonmont H, Burkhardt M, Boller M. Synthetic TiO2 nanoparticle emission from exterior facades into the aquatic environment. Environ Pollut 2008, 156(2):233-239. 10.1016/j.envpol.2008.08.004, 18824285.
35. Xia T, Kovochich M, Liong M, Madler L, Gilbert B, Shi H, Yeh JI, Zink JI, Nel AE. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS nano 2008, 2(10):2121-2134. 10.1021/nn800511k, 19206459.
36. Muller KH, Kulkarni J, Motskin M, Goode A, Winship P, Skepper JN, Ryan MP, Porter AE. pH-dependent toxicity of high aspect ratio ZnO nanowires in macrophages due to intracellular dissolution. ACS nano 2010, 4(11):6767-6779. 10.1021/nn101192z, 20949917.
37. Kraemer SM, Chiu, Van Q, Hering JG. Influence of pH and competitive adsorption on the kinetics of ligand-promoted dissolution of aluminum oxide. Environ Sci Technol 1998, 32(19):2876-2882.
38. Furrer G, Stumm W. The coordination chemistry of weathering: I. Dissolution kinetics of alumina and beryllium oxide. Geochimica et Cosmochimica Acta 1986, 50(9):1847-1860.
39. Johnson SB, Brown GE, Healy TW, Scales PJ. Adsorption of organic matter at mineral/water interfaces. 6. Effect of inner-sphere versus outer-sphere adsorption on colloidal stability. Langmuir 2005, 21(14):6356-6365. 10.1021/la047030q, 15982042.
40. Martin RB. Citrate binding of Al3+ and Fe3+. J Inorg Biochem 1986, 28(2-3):181-187.
41. Blais MJ, Berthon G. Citrate interactions in blood plasma. Quantitative study of the metal ion equilibriums in the zinc - citrate -histidinate, -glutaminate and -threoninate systems and computer simulation of the ability of citrate to mobilize the low molecular weight fraction of zinc. Inorganica Chimica Acta 1982, 67(3):109-115.
42. Pauluhn J. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol Sci 2009, 109(1):152-167. 10.1093/toxsci/kfp046, 19251949.
43. Cullen RT, Tran CL, Buchanan D, Davis JM, Searl A, Jones AD, Donaldson K. Inhalation of poorly soluble particles. I. Differences in inflammatory response and clearance during exposure. Inhal Toxicol 2000, 12(12):1089-1111. 10.1080/08958370050166787, 11114783.
44. Duffin R, Tran L, Brown D, Stone V, Donaldson K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhal Toxicol 2007, 19(10):849-856. 10.1080/08958370701479323, 17687716.
45. Tran CL, Buchanan D, Cullen RT, Searl A, Jones AD, Donaldson K. Inhalation of poorly soluble particles. II. Influence of particle surface area on inflammation and clearance. Inhal Toxicol 2000, 12(12):1113-1126. 10.1080/08958370050166796, 11114784.
46. Lanone S, Rogerieux F, Geys J, Dupont A, Maillot-Marechal E, Boczkowski J, Lacroix G, Hoet P. Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines. Particle and fibre toxicology 2009, 6:14. 10.1186/1743-8977-6-14, 2685765, 19405955.
47. Warheit DB, Webb TR, Sayes CM, Colvin VL, Reed KL. Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area. Toxicol Sci 2006, 91(1):227-236. 10.1093/toxsci/kfj140, 16495353.
48. Watanabe M, Okada M, Kudo Y, Tonori Y, Niitsuya M, Sato T, Aizawa Y, Kotani M. Differences in the effects of fibrous and particulate titanium dioxide on alveolar macrophages of Fischer 344 rats. J Toxicol Environ Heal 2002, 65(15):1047-1060.
49. Brown DM, Kinloch IA, Bangert U, Windle AH, Walter DM, Walker GS, Scotchford CA, Donaldson K, Stone V. An in vitro study of the potential of carbon nanotubes and nanofibres to induce inflammatory mediators and frustrated phagocytosis. Carbon 2007, 45(9):1743-1756.